Clinical implications of preterm infant gut microbiome development

Author(s):  
David B. Healy ◽  
C. Anthony Ryan ◽  
R. Paul Ross ◽  
Catherine Stanton ◽  
Eugene M. Dempsey
Gut Microbes ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 1951113
Author(s):  
Yan Hui ◽  
Birgitte Smith ◽  
Martin Steen Mortensen ◽  
Lukasz Krych ◽  
Søren J. Sørensen ◽  
...  

PeerJ ◽  
2017 ◽  
Vol 5 ◽  
pp. e2928 ◽  
Author(s):  
Graham Rose ◽  
Alexander G. Shaw ◽  
Kathleen Sim ◽  
David J. Wooldridge ◽  
Ming-Shi Li ◽  
...  

Background Few studies have investigated the gut microbiome of infants, fewer still preterm infants. In this study we sought to quantify and interrogate the resistome within a cohort of premature infants using shotgun metagenomic sequencing. We describe the gut microbiomes from preterm but healthy infants, characterising the taxonomic diversity identified and frequency of antibiotic resistance genes detected. Results Dominant clinically important species identified within the microbiomes included C. perfringens, K. pneumoniae and members of the Staphylococci and Enterobacter genera. Screening at the gene level we identified an average of 13 antimicrobial resistance genes per preterm infant, ranging across eight different antibiotic classes, including aminoglycosides and fluoroquinolones. Some antibiotic resistance genes were associated with clinically relevant bacteria, including the identification of mecA and high levels of Staphylococci within some infants. We were able to demonstrate that in a third of the infants the S. aureus identified was unrelated using MLST or metagenome assembly, but low abundance prevented such analysis within the remaining samples. Conclusions We found that the healthy preterm infant gut microbiomes in this study harboured a significant diversity of antibiotic resistance genes. This broad picture of resistances and the wider taxonomic diversity identified raises further caution to the use of antibiotics without consideration of the resident microbial communities.


2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Diana Taft ◽  
D Ward ◽  
N Ollberding ◽  
K Schibler ◽  
N Ambalavanan ◽  
...  

Microbiome ◽  
2014 ◽  
Vol 2 (1) ◽  
pp. 38 ◽  
Author(s):  
Maureen W Groer ◽  
Angel A Luciano ◽  
Larry J Dishaw ◽  
Terri L Ashmeade ◽  
Elizabeth Miller ◽  
...  

2020 ◽  
Author(s):  
Claire L. Granger ◽  
Nicholas D. Embleton ◽  
Jeremy M. Palmer ◽  
Christopher A. Lamb ◽  
Janet E. Berrington ◽  
...  

Gut Microbes ◽  
2016 ◽  
Vol 7 (5) ◽  
pp. 443-449 ◽  
Author(s):  
Andrew J. Gasparrini ◽  
Terence S. Crofts ◽  
Molly K. Gibson ◽  
Phillip I. Tarr ◽  
Barbara B. Warner ◽  
...  

2018 ◽  
Vol 73 (Suppl. 3) ◽  
pp. 17-23 ◽  
Author(s):  
Silvia Arboleya ◽  
M. Suárez ◽  
N. Fernández ◽  
L. Mantecón ◽  
G. Solís ◽  
...  

Background: The human gut microbiota is assembled during infancy with an increase in diversity and stability. The correct colonization and the establishment of this microbiome are linked to the early and future health status of the individual. It is known that caesarean delivery alters this optimal microbial foundation. C-section (CS) is a common obstetrician surgery; however, it is not without risk for the mother/infant dyad. The World Health Organization recommends not exceeding 10–15% of the total deliveries; nevertheless, this rate has been increasing rapidly worldwide in the last decades. Summary: This review discloses the clinical parameters for correct CS recommendation. Moreover, the major microbial changes in the infant gut microbiome acquisition as a consequence of delivery mode and medical practices surrounding it, as well as, the early and long-lasting effects for both mother and babies are discussed. In addition, some strategies for the gut microbiota restoration are analysed. The aim of this review is to show the need for the development of strategies for minimizing or limiting the impact of caesarean on the microbiome development, favouring future health.


Sign in / Sign up

Export Citation Format

Share Document